Artigo
Revisado por pares
Cost-Utility Analysis of Melphalan plus Prednisone With or Without Interferon-α2b in Newly Diagnosed Multiple Myeloma
1997; Adis, Springer Healthcare; Volume: 12; Issue: 1 Linguagem: Inglês
10.2165/00019053-199712010-00009
ISSN1179-2027
AutoresErik Nord, Finn Wislöff, Martin Hjorth, Jan Westin,
Tópico(s)Health Systems, Economic Evaluations, Quality of Life
Referência(s)